Clinical Trial Update: Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire Disorder [NA]

View source ↗

Summary

This clinical trial update reports on Dehydroepiandrosterone (DHEA) treatment for Hypoactive Sexual Desire Disorder, with current status listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoactive Sexual Desire Disorder

Drugs mentioned

• Dehydroepiandrosterone (DHEA) (dehydroepiandrosterone)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Hypoactive Sexual Desire Disorder | NA | Status: UNKNOWN